Belgian guidelines concerning drug induced alteration of coagulation and central neuraxial anesthesia. Belgian Society for Anesthesia and Resuscitation.
D000775:Anesthesia, Spinal / Q000592:standards*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001530:Belgium; D006406:Hematoma / Q000139:chemically induced* / Q000517:prevention & control*; D006407:Hematoma, Epidural, Cranial / Q000139:chemically induced / Q000517:prevention & control; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D013923:Thromboembolism / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D014812:Vitamin K